Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVP-786 for Agitation in Alzheimer's Dementia
NCT03393520Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Oct 2017
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of deudextromethorphan in agitation, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Oct 2017; status: completed.
02
Drugs
deudextromethorphan
03
Conditions
agitation
Beyond the preview
Go deeper on NCT03393520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03393520.